Deltasone (Prednisone) Dose Pack Instructions
For a standard Deltasone dose pack in adults, the FDA-approved dosing is 5-60 mg daily depending on the condition being treated, with most common short-course "burst" regimens using 40-60 mg daily for 5-10 days without requiring a taper for courses under one week. 1
Standard Dosing Parameters
The initial dose varies significantly based on disease severity and indication 1:
- Mild conditions: 5-10 mg daily
- Moderate conditions: 20-40 mg daily
- Severe conditions: 40-60 mg daily
- Maximum typical dose: 60 mg daily (though higher doses up to 200 mg have been used for specific conditions like acute multiple sclerosis exacerbations) 1
Short-Course "Burst" Therapy
For acute exacerbations requiring short-term treatment (5-10 days), use 40-60 mg daily as a single morning dose or divided into two doses, with no taper needed for courses under one week. 2 This approach is commonly used for:
- Asthma exacerbations
- Allergic reactions
- Acute inflammatory conditions
The key advantage is that tapering is unnecessary when treatment duration is brief, simplifying the regimen and improving adherence 2.
Tapering Guidelines for Longer Courses
If treatment extends beyond 10 days, gradual tapering is required to prevent adrenal insufficiency. 1 The FDA label emphasizes that "if after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly" 1.
For tapering from higher doses 3:
- >50 mg: Reduce by 10 mg every 1-2 weeks
- 50-25 mg: Reduce by 5-10 mg every 1-2 weeks
- 25-15 mg: Reduce by 2.5 mg every 2-4 weeks
- <15 mg: Reduce by 1.25-2.5 mg every 2-6 weeks
Each dose reduction should only occur when the patient is asymptomatic and inflammatory markers are normal 3.
Administration Instructions
- Take as a single morning dose to mimic natural cortisol rhythm 1
- Take with food or antacid to minimize gastric irritation 4
- Do not stop abruptly after prolonged use (>1-2 weeks) 1
- Never double doses if a dose is missed
Critical Precautions
When to Increase Dose (Stress Dosing)
Patients may need temporary dose increases during physiologic stress 5:
- Minor stress (fever, infection): Double the usual dose temporarily
- Moderate-major stress (surgery, severe illness): May require parenteral glucocorticoids and medical supervision
- Vomiting/diarrhea: Consider parenteral administration if oral absorption is compromised
Absolute Contraindications
- Active systemic fungal infections 1
- Known hypersensitivity to prednisone
- Live virus vaccination (avoid during treatment and for period after) 1
Common Pitfalls to Avoid
Stopping too quickly: Even 10 days of prednisone can suppress the HPA axis in some patients. When in doubt, taper slowly 5.
Inadequate stress coverage: Patients on chronic prednisone ≥20 mg daily for >3 weeks are at risk for adrenal crisis during acute illness and may need supplemental dosing 5.
Ignoring bone protection: For courses >3 months, consider calcium (1200-1500 mg/day), vitamin D (800-1000 IU/day), and bisphosphonates for high-risk patients 3.
Missing drug interactions: Prednisone interacts with numerous medications including NSAIDs (increased GI bleeding risk), warfarin (altered anticoagulation), and diabetic medications (hyperglycemia) 1.
Monitoring Requirements
- Baseline: Blood glucose, blood pressure, bone density (if long-term use anticipated)
- During treatment: Monitor for hyperglycemia, hypertension, mood changes, insomnia
- Long-term use: Annual bone density, ophthalmologic exams (cataracts, glaucoma), growth monitoring in children 6, 7
Special Populations
Children: Dose is 1-2 mg/kg/day (maximum 60 mg/day) for short courses 2. Growth suppression is a major concern with prolonged use, making steroid-sparing strategies essential 4, 8.
Pregnancy: Continue maintenance doses throughout pregnancy as uncontrolled disease poses greater risk than medication 4. Prednisone is preferred over other corticosteroids due to placental metabolism.
Cirrhosis: Use lower initial doses and monitor closely for complications, as patients with cirrhosis have higher rates of drug-related adverse effects 8.